Is this your company? The full strategic profile database — relevance scoring against NATO/EU priorities, technologies and programmes — is
DFM Intelligence →EU research grants
| Project | Role | Programme | EC contribution |
|---|
| Enabling advances in diagnosis, patient stratification and treatment for |
coordinator |
HORIZON-EIC-2022-PATHFINDERCHALLENGES-01 |
€2,032,900 |
| Supporting Policy Regulations and Interventions to Negate aggravated Glo |
coordinator |
HORIZON-HLTH-2023-ENVHLTH-02 |
€1,964,796 |
| SINGLE DOSE CURE OF FALCIPARUM MALARIA USING NEXT GENERATION COMBINATION |
coordinator |
HORIZON-JU-GH-EDCTP3-2025-01-two-stage |
€1,172,422 |
| NaV1.5 regulation fine-tuning as a therapy for cardiac Conduction and Ar |
participant |
HORIZON-EIC-2022-PATHFINDERCHALLENGES-01 |
€999,854 |
| Diversibus Viis Plurima Solvo |
participant |
HORIZON-CL4-2024-HUMAN-03 |
€748,875 |
| Precision Nutrition to optimize immune response for metabolic health |
participant |
HORIZON-EIC-2023-PATHFINDERCHALLENGES-01 |
€683,050 |
| Data driven Excellence in Training of Epidemiological, Clinical, Technol |
participant |
HORIZON-MSCA-2025-DN-01 |
€610,572 |
| BIO-MICRO: Biomarkers and Intervention Outcomes in Micronutrient Optimiz |
coordinator |
HORIZON-MSCA-2024-DN-01 |
€610,572 |
| Multilevel inflammatory regulation in cardiometabolic disease |
coordinator |
HORIZON-MSCA-2022-DN-01 |
€541,119 |
| Smart Implant for Magnetic Anastomotic Healing and Leakage Evaluation |
participant |
HORIZON-EIC-2024-TRANSITION-01 |
€470,894 |
| Orchestrating next-generation mobile modular laboratories for pandemic m |
coordinator |
HORIZON-CL3-2021-DRS-01 |
€385,250 |
| Endoscopic brush cytology and single cell clinal dynamics of early easop |
participant |
HORIZON-MISS-2023-CANCER-01 |
€345,625 |
| Preparedness, Research and Surveillance Network for infectious Diseases |
participant |
HORIZON-JU-GH-EDCTP3-2025-03-two-stage |
€297,564 |
| Beyond COVID |
thirdParty |
HORIZON-INFRA-2021-EMERGENCY-01 |
€0 |
| EXPeriment driven and user eXPerience oriented analytics for eXtremely P |
participant |
HORIZON-CL4-2022-DATA-01 |
€0 |
| Transcription Factor Gene Therapy for Bradyarrhythmias |
thirdParty |
HORIZON-EIC-2022-TRANSITION-01 |
€0 |
Defence Finance Monitor is an analytical and informational product. Award data is official TED; the paid Annual Professional subscription is handled on DFM Analysis.